Renal function and structure in subacute hepatic failure

Journal of Gastroenterology and Hepatology (Australia)

Volumn 15, Issue 11, 2000, Pages 1318-1324

  Bal, Chandrasekhar ^a   Longkumert, Tali ^a   Patel, Chetan ^a   Gupta, Siddhartha Dutta ^a   Acharya, Subrat Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Effective renal plasma flow; Glomerular filtration rate; Renal failure; Subacute hepatic failure

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; LIVER FAILURE; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0033664386     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2000.02337.x     Document Type: Article

References (18)

1. Recommendations of the International Association for the study of liver sub-committee on nomenclature of acute and subacute liver failure
2. Subacute hepatic failure
3. Late onset hepatic failure: Clinical, serological and histological features
4. Subacute hepatitis
5. Subacute hepatic failure. Is it a distinct entity
6. Fulminant hepatic failure
7. Early indicators of prognosis in fulminant hepatic failure
8. Acute liver failure. Experience with 145 patients
9. Measurement of glomerular filtration rate: Single injection plasma clearance method without urine collection
10. 131I]-hippuran using a single injection and one or two blood samples
11. Acute liver failure - Should we redefine the syndrome?
12. Fulminant hepatitis in a tropical population: Clinical course, cause, and early predictors of outcome
13. Prognostic value of arterial pressure, endogenous vasoactive systems and renal fucntion in cirrhotic patients admitted to the hospital for the treatment of ascites
14. Hepatorenal syndrome
15. The hepatorenal syndrome - Newer perspectives
16. The hepatorenal syndrome
17. A rational approach to the hepatorenal syndrome
18. A preliminary open trial on interferon stimulator (SNMC) derived from glycyrrhiza glabra in the treatment of subacute hepatic failure